What is Babyscripts?
Babyscripts is a technology company dedicated to transforming maternity care delivery. Leveraging a mobile application, remote patient monitoring, and care management services, Babyscripts addresses critical issues within maternal health, including access to care, physician shortages, and health inequity. The company's mission is to improve pregnancy outcomes with the ultimate goal of eliminating preventable maternal mortality by enhancing access to data-driven care for all expectant mothers.
How much funding has Babyscripts raised?
Babyscripts has raised a total of $41M across 6 funding rounds:
Other Financing Round
$900K
Other Financing Round
$1M
Private Equity
$7.9M
Series A
$5.7M
Other Financing Round
$6M
Series B
$19.5M
Other Financing Round (2013): $900K with participation from Kensington Partners and Ense Group
Other Financing Round (2015): $1M led by Kensington Capital Partners Limited
Private Equity (2016): $7.9M, investors not publicly disclosed
Series A (2017): $5.7M featuring Ysios Capital, Chemo Group, P5 Health Ventures, and CG Health Ventures
Other Financing Round (2019): $6M backed by NueCura Partners, StartUp Health, and Philips
Series B (2021): $19.5M with participation from Philip Ventures, Texas Medical Center, Atlantic Health System, Cigna Ventures, CU Healthcare Innovation Fund, and MemorialCare Innovation Fund
Key Investors in Babyscripts
Ysios Capital
Ysios Capital is a venture capital firm specializing in life sciences, investing in innovative biotechnology companies worldwide to develop novel therapies for high unmet medical needs.
Chemo Group
Chemo Group is a pharmaceutical company involved in the development and commercialization of medicines. Their investment in Babyscripts suggests an interest in digital health solutions that complement pharmaceutical interventions in patient care.
P5 Health Ventures
P5 Health Ventures focuses on investing in companies that enhance healthcare and promote healthier living, with a portfolio that includes diagnostics, AI, longevity, and wellness solutions.
What's next for Babyscripts?
The substantial capital raised by Babyscripts, particularly the recent Series B financing, positions the company for accelerated scaling and market penetration. This investment will likely support the expansion of its technological infrastructure, further development of its remote monitoring capabilities, and broader outreach to healthcare providers and patients. Strategic partnerships and continued innovation in addressing maternal health disparities are anticipated as key future initiatives.
See full Babyscripts company page
